Autoimmune phenomena as prognostic markers of response to adjuvant interferon therapy for melanoma

Clin Transl Oncol. 2007 Mar;9(3):125-6. doi: 10.1007/s12094-007-0025-4.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Autoantibodies / blood
  • Autoimmune Diseases / chemically induced
  • Autoimmunity*
  • Chemotherapy, Adjuvant*
  • Clinical Trials, Phase III as Topic / statistics & numerical data
  • Dose-Response Relationship, Drug
  • Follow-Up Studies
  • Humans
  • Immune System / drug effects
  • Interferon-alpha / administration & dosage
  • Interferon-alpha / adverse effects*
  • Interferon-alpha / pharmacology
  • Interferon-alpha / therapeutic use
  • Melanoma / drug therapy*
  • Melanoma / immunology
  • Melanoma / mortality
  • Prognosis
  • Purpura, Thrombocytopenic, Idiopathic / chemically induced
  • Randomized Controlled Trials as Topic
  • Survival Analysis
  • Thyrotoxicosis / chemically induced
  • Vitiligo / chemically induced

Substances

  • Autoantibodies
  • Interferon-alpha